title: [Anti-Pseudomonas aeruginosa antibodies and lung disease in cystic fibrosis]
abstract: The aim of our study was to diagnose and to control three aspects of the evolution of lung disease in CF: the absence of infection, the intermittent colonization and chronic infection by Pseudomonas aeruginosa. Therefore a study of anti-pseudomonas antibodies (Ab) (anti-protease, anti-elastin and antihexo-toxin A) for diagnosis and follow-up of CF patients was considered. Moreover, we related the presence of Ab to the sputum culture, to FEV1, to patient age and to genotype. Tbe Ab were dosed in 121 patients by quantitative ELISA method. Values < 1: 500 were considered negative, values> 1: 500 and < 1:1250 borderline, and > 1:1250 positive. 16.5% of patients did not have Ab, 17% had borderline values and 69.5% had positive values. All the patients with negative Ab had negative sputum culture; 47% of patients with borderline values had at least one positive culture while 53% were negative. 87% of patients with positive values had chronic colonization, 13% intermittent colonization. The increase in the Ab rate is statistically related to a more severe lung disease (p < 0.013). The presence of a severe mutation (?F 508) is related to positive values of Ab. Evaluation of anti-Pseudomonas aeruginosa is an important tool for diagnosis and follow-up of CF lung disease
authors.affiliation: Centro Regionale Fibrosi Cistica, 2 Divisione di Pediatria, Ospedale dei Bambini "G. Di Cristina", Palermo, Italy.
authors.forename: E.
authors.initials: E
authors.lastname: Pardo
authors.forename: L.
authors.initials: L
authors.lastname: Iapichino
authors.forename: M.
authors.initials: M
authors.lastname: Collura
authors.forename: M.L.
authors.initials: ML
authors.lastname: Furnari
authors.forename: L.
authors.initials: L
authors.lastname: Termini
authors.forename: A.
authors.initials: A
authors.lastname: Cascio
authors.forename: S.
authors.initials: S
authors.lastname: Giordano
vernacular_title: Anticorpi anti Psudomonas aeruginosa e malattia polmonare in fibrosi cistica.